AGER and diabetes mellitus: The most predictive PBMC profile for renal disease in diabetes in humans was an increase in the cell surface expression of the AGE-R1, in the context of a decrease in RAGE, which warrants further investigation as a biomarker for progressive DN in large patient cohorts since these markers were also associated with creatinine clearance in type 2 diabetes.